Topics

TLR 4 Inhibitor TAK-242 As a New Potential Anti-RA Drug

08:00 EDT 13 Mar 2020 | Medscape

Is the TLR4 inhibitor TAK-242 another potentially effective treatment option for rheumatoid arthritis?
Arthritis Research & Therapy

Original Article: TLR 4 Inhibitor TAK-242 As a New Potential Anti-RA Drug

NEXT ARTICLE

More From BioPortfolio on "TLR 4 Inhibitor TAK-242 As a New Potential Anti-RA Drug"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topic

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group.

All rights reserved. All other trademarks recognized. Copyright © 2020 ND2A Group. Site developed by Alacrify Ltd

.